Nectar
PrivateLast Round
Series A
Dec 20, 2022
Total Funding Raised
$24.5M
Company Overview
Nectar is a healthtech company that provides a comprehensive, vertically integrated allergy healthcare platform offering personalized, patient-centric allergy care.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Precision Medicine, D2C Brands, Subscription Commerce
Business Model
B2C
Customer Profile
Hardware + Subscription, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nectar Comparables
Compare Nectar with similar companies based on industry and business-model similarity.
Nectar Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 20, 2022 | ||||
| Seed | Mar 17, 2022 |
Key People
Founding team and executive leadership
Nectar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Juxtapose | Series A, Seed |
| Obvious Ventures | Series A, Seed |
| Harmony Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 117% MoM, reaching 61.5K.
- Dec 20, 2022
$17M round led by Harmony Partners.
Nectar Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nectar's valuation, stock price, and market status.